A detailed history of Lpl Financial LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 41,356 shares of LUCD stock, worth $31,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,356
Previous 41,457 0.24%
Holding current value
$31,430
Previous $33,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$0.75 - $0.88 $75 - $88
-101 Reduced 0.24%
41,356 $33,000
Q2 2024

Aug 07, 2024

BUY
$0.67 - $1.04 $2,964 - $4,602
4,425 Added 11.95%
41,457 $33,000
Q1 2024

May 10, 2024

BUY
$0.81 - $1.52 $3,565 - $6,691
4,402 Added 13.49%
37,032 $29,000
Q4 2023

Feb 14, 2024

BUY
$1.16 - $1.54 $4,906 - $6,514
4,230 Added 14.89%
32,630 $46,000
Q3 2023

Nov 13, 2023

BUY
$1.17 - $1.65 $16,379 - $23,100
14,000 Added 97.22%
28,400 $33,000
Q2 2022

Aug 12, 2022

BUY
$1.73 - $3.44 $24,912 - $49,536
14,400 New
14,400 $33,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $29.3M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.